APA (7th ed.) Citation

DX, L., YH, Z., J, T., & JS, H. (2025). [Clinical Analysis of Ixazomib-Based Chemotherapy Regimens in the Treatment of Newly Diagnosed Multiple Myeloma with 1q21 Amplification]. Zhongguo shi yan xue ye xue za zhi, 33(6), 1640. https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.06.014

Chicago Style (17th ed.) Citation

DX, Lin, Zhuang YH, Tang J, and Hu JS. "[Clinical Analysis of Ixazomib-Based Chemotherapy Regimens in the Treatment of Newly Diagnosed Multiple Myeloma with 1q21 Amplification]." Zhongguo Shi Yan Xue Ye Xue Za Zhi 33, no. 6 (2025): 1640. https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.06.014.

MLA (9th ed.) Citation

DX, Lin, et al. "[Clinical Analysis of Ixazomib-Based Chemotherapy Regimens in the Treatment of Newly Diagnosed Multiple Myeloma with 1q21 Amplification]." Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 33, no. 6, 2025, p. 1640, https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.06.014.